Kronos Bio, Inc.

KRON · NASDAQ
Analyze with AI
3/31/2025
12/31/2024
9/30/2024
6/30/2024
Operating Activities
Net Income-$8-$26-$14-$16
Dep. & Amort.$0$0-$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$2$2$2
Change in WC-$8-$5$12-$3
Other Non-Cash$3$16-$12$1
Operating Cash Flow-$13-$13-$12-$16
Investing Activities
PP&E Inv.$0-$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$4-$10-$24-$6
Inv. Sales/Matur.$24$33$41$47
Other Inv. Act.$0$0$0$0
Investing Cash Flow$20$22$17$40
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0-$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$7$10$5$24
Supplemental Information
Beg. Cash$87$77$72$46
End Cash$94$87$77$70
Free Cash Flow-$13-$13-$12-$16
Kronos Bio, Inc. (KRON) Financial Statements & Key Stats | AlphaPilot